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Serum S-adenosylmethionine, but not methionine, increases
in response to overfeeding in humans
AK Elshorbagy1, F Jernerén2, D Samocha-Bonet3,4, H Refsum2,5 and LK Heilbronn4,6
BACKGROUND: Plasma concentration of the methyl donor S-adenosylmethionine (SAM) is linearly associated with body mass
index (BMI) and fat mass. As SAM is a high-energy compound and a sensor of cellular nutrient status, we hypothesized that SAM
would increase with overfeeding.
METHODS: Forty normal to overweight men and women were overfed by 1250 kcal per day for 28 days.
RESULTS: Serum SAM increased from 106 to 130 nmol/l (P= 0.006). In stratiﬁed analysis, only those with weight gain above the
median (high-weight gainers; average weight gain 3.9 ± 0.3 kg) had increased SAM (+42%, P= 0.001), whereas low-weight gainers
(weight gain 1.5 ± 0.2 kg) did not (Pinteraction = 0.018). Overfeeding did not alter serum concentrations of the SAM precursor,
methionine or the products, S-adenosyl-homocysteine and homocysteine. The SAM/SAH (S-adenosylhomocysteine) ratio was
unchanged in the total population, but increased in high-weight gainers (+52%, P= 0.006, Pinteraction = 0.005). Change in SAM
correlated positively with change in weight (r= 0.33, P= 0.041) and fat mass (r= 0.44, P= 0.009), but not with change in protein
intake or plasma methionine, glucose, insulin or low-density lipoprotein (LDL)-cholesterol.
CONCLUSION: Overfeeding raised serum SAM in proportion to the fat mass gained. The increase in SAM may help stabilize
methionine levels, and denotes a responsiveness of SAM to nutrient state in humans. The role of SAM in human energy metabolism
deserves further attention.
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INTRODUCTION
S-adenosylmethionine (SAM) is a high-energy compound that
is synthesized from the essential sulfur amino acid methionine.1
SAM-dependent methylation reactions include DNA methylation,
post-translational protein modiﬁcations and synthesis of hormones,
creatine and phosphatidylcholine.1 Phosphatidylcholine is the major
phospholipid constituent of lipoproteins exported by the liver.
S-adenosylhomocysteine (SAH), and subsequently homocysteine,
are products of SAM-dependent methylation. As a high SAH
concentration inhibits methyltransferases, the SAM/SAH ratio is
considered as an index of cellular methylation potential.1 Elevated
plasma SAH is associated with lower plasma SAM/SAH ratio and
hypomethylation of lymphocyte DNA in humans.2
Positive associations of plasma SAM and SAH with body mass
index (BMI) were ﬁrst highlighted in 2009, and subsequently
conﬁrmed.3,4 In 610 older people, we found that plasma SAM was
strongly associated with fat mass and trunk fat/total fat ratio.5
Subjects in the upper SAM quartile had, on average, 6 kg higher
fat mass, after multiple adjustments, whereas plasma methionine
and SAH were not independently associated with fat mass. We
also observed that SAM correlated with fat mass only in
overweight, but not in normal-weight subjects.5 This suggested
that the association of SAM with adiposity was linked to the
presence of nutrient oversupply.
SAM synthesis by methionine adenosyltransferase (MAT) is an
energy-consuming reaction in which all three high-energy ATP
bonds are hydrolyzed.1 Activation of MAT requires the presence of
both methionine and ATP.6 In vitro, glucose increases MAT activity
and SAM concentration,7 suggesting that SAM synthesis increases
with nutrient abundance. However, the cross-sectional studies
linking SAM with obesity cannot clarify whether SAM elevation
predisposes to, accompanies or follows the development of
obesity. To test the dynamics of this relationship, we investigated




Forty healthy sedentary non-smoking adults (20/20 men/women)
were studied using an overfeeding protocol, as detailed
previously.8,9 The protocol was approved by the Human Research
and Ethics Committee at St Vincent’s Hospital, Sydney.
All volunteers gave written, informed consent. The study is
registered at ClinicalTrials.gov NCT00562393.
Overfeeding
Participants were overfed for 28 days by 1250 kcal per day above
baseline energy requirements. Nutrient composition at baseline
was 30% fat, 15% protein and 55% carbohydrate, and during
overfeeding was 45% fat, 15% protein and 40% carbohydrate.
At baseline (D0) and day 28 (D28), fasting blood samples were
obtained, and fat mass, lean mass and central abdominal fat
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were measured using dual-energy X-ray absorptiometry (Lunar
DPX-Lunar Radiation, Madison, WI, USA).
Serum was allowed to clot at room temperature for 15 min
before being centrifuged at 4 °C, aliquoted and snap-frozen
in liquid nitrogen, before storage at − 80 °C until analysis. Serum
methionine, SAM, SAH and total homocysteine were measured
with liquid chromatography tandem-mass spectrometry using
a modiﬁcation of a previously described method.10 The method
was modiﬁed to include SAM and SAH, using a Prominence
LC-20ADXR binary pump (Shimadzu, Kyoto, Japan) coupled
to a QTRAP 5500 hybrid triple quadropole mass spectrometer
(AB Sciex, Framingham, MA, USA). Analytes were resolved on a
Kinetex Core Shell C18 (30 × 4.6 mm, 2.6 μm; Phenomenex,
Torrance, CA, USA). Quantitation was based on comparisons with
standard curves corrected for the presence of isotopically labeled
internal standards. The coefﬁcients of variation for methionine,
total homocysteine, SAM and SAH were between 3 and 8%.
Fasting serum glucose was analyzed using a glucose oxidase
electrode (YSI Life Sciences, Yellow Springs, OH, USA), and insulin
was measured using a radioimmunoassay (Linco Research,
St Charles, MO, USA).
Statistical analysis
Data are presented as mean ± s.e.m. Repeated measures analysis
of variance was used to compare D0 and D28 values in the
total population, and to test for interactions by weight gain.
High-weight gainers were deﬁned as those with weight gain
above the median. Partial correlations, adjusted for age and
gender, were used to evaluate the associations of changes in SAM,
with changes in parameters of interest. PASW Statistics for Mac
(20.0; SPSS Inc., Chicago, IL, USA) was used for analysis.
RESULTS
Population characteristics
As reported, the participants were 20 males and 20 females, had a
mean age of 36.7 ± 1.9 years and had an average weight gain of
2.8 kg on D28. Table 1 shows selected characteristics at D0 and
D28 in the total population and separately in those with high- and
low-weight gain. High- and low-weight gainers had an average
weight gain of 3.9 ± 0.3 and 1.5 ± 0.2 kg, respectively (Po0.001).
There was no signiﬁcant difference between the groups in age or
gender distribution, or in baseline weight, BMI, fat mass, lean mass
or central fat (P40.32). However, high-weight gainers had higher
baseline energy intake (P= 0.029) and fat intake (P= 0.019).
After 28 days of overfeeding, dietary intakes of fat, protein and
total energy increased signiﬁcantly in the total population
(Po0.001 for all, Table 1), and tended to be higher in those
who gained more weight; however, this did not reach statistical
signiﬁcance (Table 1).
Overfeeding increased plasma glucose, insulin and homeostatic
model of insulin resistance (HOMA-IR); however, there was
no signiﬁcant difference between low- and high-weight gainers
in the baseline values or in the magnitude of increase in these
parameters (Table 1).
Effect of overfeeding on serum SAM and related metabolites
Overfeeding increased serum SAM by 22% (P= 0.006), but did not
inﬂuence methionine (Figure 1a–c). In stratiﬁed analysis, only
those with high-weight gain had an increase in SAM (by 42%,
P= 0.001), whereas low-weight gainers did not (Pinteraction = 0.018;
Figure 1d). Similarly, serum SAM/SAH ratio increased only in those
with higher weight gain (P= 0.006), but not in those with low-
weight gain (Pinteraction = 0.015; Figure 1d), or the total population.
Serum total homocysteine on D28 did not differ signiﬁcantly from
baseline (Figure 1i and j).
Correlates of delta SAM
Change in serum SAM correlated positively with change in fat
mass (r= 0.44, P= 0.009) and in body weight (r= 0.33, P= 0.041)
after adjustment for age and gender. There were no associations
of change in serum SAM with changes in lean mass, protein intake
(g per day), serum methionine, low-density lipoprotein (LDL)-
cholesterol, glucose, insulin or HOMA-IR (P⩾ 0.41 for all).
DISCUSSION
Plasma SAM correlates with BMI and fat mass in humans.3–5
Possible explanations include the following: (1) SAM changes
dynamically with alterations in energy balance or fat accretion,
and hence acts as a marker of nutrient status, along with
other high-energy compounds;11 (2) SAM reﬂects a genetic or
Table 1. Characteristics at baseline (D0) and after overfeeding (D28) of the total study population and subgroups with low- or high-weight gaina
Total population (n= 40) Low-weight gain (n=20) High-weight gain (n=20) P-values
D0 D28 D0 D28 D0 D28 Time Group Time*group
Age, years 36.7 (1.9) — 34.9 (2.4) — 38.6 (2.9) — — 0.32b —
Male, N 20 — 9 — 11 — — 0.75c —
Weight, kg 75.3 (1.9) 78.1 (1.9) 75.0 (2.9) 76.6 (3.0) 75.6 (2.4) 79.6 (2.5) o0.001 0.64 o0.001
BMI, kg m− 2 25.6 (0.6) 26.6 (0.6) 25.9 (0.8) 26.5 (0.8) 25.3 (0.8) 26.6 (0.8) o0.001 0.84 o0.001
Fat mass, kg 25.5 (1.5) 27 (1.5) 25.6 (2.0) 26.2 (1.9) 25.3 (2.2) 27.7 (2.3) o0.001 0.81 0.001
Lean mass, kg 47.2 (1.4) 47.9 (1.4) 46.4 (2.2) 46.7 (2.2) 48.0 (1.9) 49.0 (1.9) 0.001 0.51 0.053
Central fat, kg 1.9 (0.1) 2.1 (0.1) 2.0 (0.2) 2.1 (0.2) 1.9 (0.2) 2.1 (0.2) o0.001 0.99 0.024
Energy, kcal per day 1973 (103) 3080 (139) 1827 (153) 2747 (145) 2128 (132) 3414 (208) o0.001 0.029 0.069
Fat intake, % 34.0 (1.1) 45.3 (0.7) 32.3 (1.7) 45.3 (0.7) 36.0 (1.3) 45.3 (1.1) o0.001 0.17 0.12
Fat intake, g per day 77 (5) 155 (6) 69 (8) 140 (8) 86 (6) 171 (8) o0.001 0.019 0.12
Protein intake, % 18.9 (0.7) 16.1 (0.5) 19.3 (0.8) 16.4 (0.7) 18.6 (1.1) 15.8 (0.7) o0.001 0.51 0.88
Protein intake, g per day 90 (6) 120 (6) 86 (9) 110 (7) 95 (8) 131 (9) o0.001 0.19 0.14
LDL-C, mmol l− 1 2.8 (0.1) 2.8 (0.1) 2.8 (0.2) 2.8 (0.2) 2.9 (0.2) 2.9 (0.2) 0.94 0.64 0.76
Glucose, mmol l− 1 4.5 (0.1) 4.6 (0.1) 4.4 (0.1) 4.5 (0.1) 4.5 (0.1) 4.6 (0.1) 0.027 0.27 0.87
Insulin, pmol l− 1 69.1 (3.8) 78.5 (3.5) 70.6 (5.0) 82.5 (5.8) 67.6 (5.7) 74.5 (4.0) 0.007 0.41 0.46
HOMA-IR 1.9 (0.1) 2.2 (0.1) 1.9 (0.1) 2.4 (0.2) 1.9 (0.2) 2.1 (0.1) 0.004 0.54 0.35
Abbreviations: ANOVA, analysis of variance; HOMA-IR, homeostatic model of insulin resistance; LDL-C, low-density lipoprotein-cholesterol. aData are presented
as mean (s.e.m.). P-values are from repeated measures ANOVA, unless otherwise indicated. bIndependent samples t-test. cFisher’s exact test.
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epigenetic signature that is associated with obese phenotypes;
or (3) nutrient-induced increases in insulin and glucose concen-
trations enhance SAM synthesis, as observed in vitro.7
Our ﬁnding that SAM increases following short-term overfeeding
in a weight-gain-dependent manner, independently of insulin and
glucose, supports the ﬁrst explanation.
The present ﬁndings parallel several observations. Monteiro
et al.12 observed that children with higher erythrocyte SAM had
higher energy intake normalized to their body weight. Zucker fatty
rats, in which a leptin receptor mutation produces hyperphagia
and obesity, have markedly increased SAM in the liver13
and pancreas.14 Conversely, conditions characterized by inability
to maintain cellular energy levels, such as septic shock and
hypoxia, result in MAT inactivation (reviewed in Mato et al.1).
In HepG2 cells, exposure to insulin and glucose induced MAT
activity and increased intracellular SAM.7 However, we found no
correlation between change in serum insulin or glucose and
change in SAM. LDL-cholesterol, a surrogate marker of lipopro-
teins that incorporate the phosphatidylcholine synthesized by
SAM-dependent methylation, might be expected to correlate with
change in SAM. Yet, the change in serum SAM was unrelated to
LDL-cholesterol, consistent with observations that the plasma SAM
association with obesity was independent of LDL-cholesterol.5
However, it remains possible that LDL-particle composition is
altered secondary to changes in SAM.15
High intake of methionine and methionine-rich animal-derived
protein is associated with obesity,16,17 whereas plasma methionine
is unrelated to BMI or fat mass.5 The ﬁnding that serum methionine
is not altered by overfeeding suggests that methionine concentra-
tions are tightly regulated in the face of increased intake by
conversion to SAM. In support of this, plasma SAM rises several-fold
with methionine loading.18 A limitation of our study is that data on
serum folate and B12, which are required for homocysteine
re-methylation to methionine, were not available, although
B-vitamins were not the major determinants of plasma SAM.4
Several metabolic and lifestyle determinants of plasma SAM
have been reported, including plasma methionine and choline
(positive), smoking (negative), as well as polymorphisms of MAT1A
in certain subgroups.4 Plasma SAM is also elevated in a variety of
clinical conditions, including cardiovascular disease,19 Alzheimer’s
disease20 and liver disease.21 There are scant data in humans on
the relationship of plasma SAH and SAM with tissue levels of these
metabolites, which tend to be several orders of magnitude higher.
Mathematical modeling based on known kinetics of the methio-
nine cycle depicts the plasma SAM and SAH concentration as a
function of export from the liver and peripheral tissues, balanced
by urine excretion, with no net movement of SAM or SAH from the
plasma to tissues.22 Plasma SAH indeed increases with a
decreased glomerular ﬁltration rate in humans.23 Both pharmaco-
logic folic acid supplementation24 and methionine loading18
produce clear increases in plasma SAM, likely resulting from
increased hepatic SAM formation. Available evidence therefore
suggests that increased plasma SAM in overfed subjects may reﬂect
changes in SAM metabolism in the liver and/or peripheral tissues.
Our data raise the question of whether the dynamic response
of SAM to nutrient status in humans has epigenetic implications.
In one human study, B-vitamin treatment that increased plasma
SAM had no effect on global DNA methylation.24 However,
serum SAM/SAH ratio, which also increased in the present study,
was associated with global DNA methylation in humans.2
The evidence for associations of global DNA methylation with
obesity is inconsistent, with studies reporting positive, negative
or no associations (reviewed in van Dijk et al.25). Alterations
in gene-speciﬁc methylation patterns, however, have been
demonstrated in obese individuals,25 and may be restored by
weight loss.26 Further, short-term overfeeding in humans was
associated with widespread gene-speciﬁc methylation changes in
skeletal muscle.27 Whether the SAM changes observed in the
present study are linked to gene-speciﬁc methylation patterns
observed in overfeeding and obesity is an interesting question for
further study.
In summary, serum SAM increased with short-term overfeeding,
in proportion to the fat mass gained. This ﬁnding extends
previously reported cross-sectional associations of SAM with
BMI and fat mass,3–5 and further documents an interaction of
the sulfur amino-acid pathway with energy metabolism. Serum
methionine was unchanged, despite increased protein intake,
suggesting that conversion to SAM may stabilize methionine
levels with high intake. Whether the overfeeding-associated SAM
changes have epigenetic consequences, particularly in genes
whose methylation pattern is linked to BMI,25,27,28 is an interesting
































































































Figure 1. Fasting serum parameters in the total study population (a,
c, e, g, i; N= 40) and separately in low- (N= 20) or high- (N= 20)
weight gainers (b, d, f, h, j) at baseline (Day 0) and after 28 days
of overfeeding (Day 28). SAH, S-adenosyl homocysteine; SAM,
S-adenosyl-methionine; tHcy, total homocysteine. **P⩽ 0.006 versus
D0. Pinteraction by repeated measures analysis of variance for time
(Day 0 versus Day 28) by group (low- versus high-weight gainers)
interaction is indicated.
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